Crossmark

Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

Published Online: 2014-09-18

Authors

Nagai, Toshihiro

Sato, Masato

Kobayashi, Miyuki

Yokoyama, Munetaka

Tani, Yoshiki

Mochida, Joji
License Information

Text and Data Mining valid from 2014-09-18

Version of Record valid from 2014-09-18
More Information

Article History

Received: 16 November 2013

Accepted: 13 August 2014

First Online: 18 September 2014

Document is current